Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service
"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS
Ergebnis verändern
- Publikationstyp
Publikationstyp- erschienen in
- Verlag
- Geographic terms
- Sprache
-
1
von Ercan, Ayse Bahar ; Aronson, Melyssa ; Fernandez, Nicholas R ; et al.
In The Lancet Oncology May 2024 25(5):668-682
-
2
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
von Schwartz, Gregory G. ; Gabriel Steg, P.h. ; Bhatt, Deepak L. ; et al.
In Journal of the American College of Cardiology 3 August 2021 78(5):421-433
-
3
von Schwartz, Gregory G. ; Steg, Ph. Gabriel ; Bhatt, Deepak L. ; et al.
In The Lancet Diabetes & Endocrinology August 2019 7(8):618-628
-
4
von F. Thalasso ; K. Walter Anthony ; O. Irzak ; et al.
Hydrology and Earth System Sciences, Vol 24, Pp 6047-6058 (2020)
Schlagworte: Technology; Environmental technology. Sanitary engineering; TD1-1066; Geography. Anthropology. Recreation; Environmental sciences; GE1-350
-
5
von Eades, Michael J. ; Chaleff, Ethan S. ; Venneri, Paolo F. ; et al.
In Progress in Nuclear Energy November 2016 93:397-405
-
6
Schlagworte: Alirocumab; Prevention; MI types; Mortality
-
7
Schlagworte: Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Peripheral Vascular Disease; Cardiovascular System & Cardiology; acute coronary syndrome; alirocumab; cholesterol; mortality; PCSK9 protein; MONOCLONAL-ANTIBODY; REDUCING LIPIDS; EFFICACY; SAFETY; EVOLOCUMAB; PCSK9; Aged; Antibodies; Monoclonal; Humanized; LDL; Double-Blind Method; Drug Therapy; Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Injections
-
8
Schlagworte: Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Peripheral Vascular Disease; Cardiovascular System & Cardiology; alirocumab; acute coronary syndrome; dyslipidemias; guideline; CARDIOVASCULAR OUTCOMES; STATIN THERAPY; ADDING EZETIMIBE; BENEFIT; EVENTS; PCSK9; Cardiovascular System & Hematology; 1102 Cardiorespiratory Medicine and Haematology; 1103 Clinical Sciences; 1117 Public Health and Health Services
-
9
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
von Schwartz, G ; Szarek, M ; Bittner, V ; et al.
Schlagworte: acute coronary syndrome; lipoprotein(a); low-density lipoprotein cholesterol; PCSK9 inhibitor; info:eu-repo/semantics/article
-
10
von Chaleff, Alec ; Gang, Anjulie ; Relich, Ryan F. ; et al.
In Diagnostic Microbiology & Infectious Disease September 2024 110(1)
-
11
von Ray, K ; Colhoun, H ; Szarek, M ; et al.
Schlagworte: Aged; Antibodies, Monoclonal, Humanized; Cardiovascular Disease; Diabetes Complication; Female; Human; Male; Middle Aged; info:eu-repo/semantics/article
-
12
von UCL - SSS/IREC/PEDI - Pôle de Pédiatrie ; UCL - SSS/IREC/SLUC - Pôle St.-Luc ; UCL - (SLuc) Service d'hématologie et d'oncologie pédiatrique ; et al.
The Lancet. Oncology, Vol. 25, no. 5, p. 668-682 (2024)
Schlagworte: info:eu-repo/semantics/article
-
13
von UCL - (SLuc) Service de gastro-entérologie et hépatologie pédiatrique ; UCL - SSS/IREC/PEDI - Pôle de Pédiatrie ; Tabori, Uri ; et al.
The Lancet Oncology, Vol. 25, no.5, p. 668-682 (2024)
Schlagworte: info:eu-repo/semantics/article
-
14
von Schwartz G. G. ; Steg P. G. ; Szarek M. ; et al.
Schlagworte: Alirocumab; ACS
-
15
von Blandin, Anne-Florence ; Giglio, Ross ; Graham, Maya Srikanth ; et al.
ISSN:1078-0432 ; ISSN:1557-3265 ; Clinical Cancer Research, vol. 29 (14), (2651-2667.
Schlagworte: Science & Technology; Life Sciences & Biomedicine; Oncology; ANAPLASTIC LYMPHOMA KINASE; RECEPTOR TYROSINE KINASE; INHIBITOR; FUSION; GENE; EXPRESSION; CANCER; PF-06463922; PROTEIN; CELLS; Mice; Animals; Glioblastoma; Retrospective Studies; Protein Kinase Inhibitors; Glioma; 1112 Oncology and Carcinogenesis; Oncology & Carcinogenesis; 3202 Clinical sciences; 3211 Oncology and carcinogenesis
-
16
von Goodman, Shaun G. ; Aylward, Philip E. ; Szarek, Michael ; et al.
Schlagworte: alirocumab; cholesterol; coronary artery bypass graft; lipids; PCSK9; 03 Good Health and Well-being; 03 Salud y bienestar
-
17
von Bittner, Vera A. ; Szarek, Michael ; Aylward, Philip E. ; et al.
Schlagworte: acute coronary syndromes; alirocumab; low-density lipoprotein cholesterol; major adverse cardiovascular events; proprotein convertase subtilisin/kexin type 9 inhibition; 03 Good Health and Well-being; 03 Salud y bienestar
-
18
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
-
19
von Roe, Matthew T. ; Li, Qian H. ; Bhatt, Deepak L. ; et al.
0009-7322 ; Circulation
Schlagworte: Human medicine
-
20
von Jukema, J. Wouter ; Szarek, Michael ; Zijlstra, Laurien E. ; et al.
0735-1097 ; Journal of the American College of Cardiology
Schlagworte: Human medicine
-
21
von White, Harvey D. ; Steg, Ph. Gabriel ; Harrington, Robert A. ; et al.
European heart journal 40(33), 2801-2809 (2019). doi:10.1093/eurheartj/ehz299 special issue: "Focus Issue on LIPIDS"
Schlagworte: info:eu-repo/classification/ddc/610
-
22
von Szarek, Michael ; White, Harvey D. ; Schwartz, Gregory G. ; et al.
ISSN:0735-1097 ; ISSN:1558-3597 ; Journal Of The American College Of Cardiology, vol. 73 (4), (387-396.
Schlagworte: Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Cardiovascular System & Cardiology; acute coronary syndrome; alirocumab; total events; ACUTE CORONARY SYNDROMES; STATIN THERAPY; REDUCTION; Aged; Antibodies; Monoclonal; Humanized; Drug Therapy; Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; ODYSSEY OUTCOMES Committees and Investigators; 1102 Cardiorespiratory Medicine and Haematology; 1117 Public Health and Health Services; Cardiovascular System & Hematology; 3201 Cardiovascular medicine and haematology
-
23
von Hagström, Emil ; Steg, Philippe Gabriel ; Szarek, Michael ; et al.
ISSN: 0009-7322.
Schlagworte: PCSK9 inhibitors; heart disease risk factors; LDL; cholesterol; apolipoproteins B; acute coronary syndrome; MESH: Acute Coronary Syndrome; MESH: Antibodies; Monoclonal; Humanized; MESH: Hydroxymethylglutaryl-CoA Reductase Inhibitors; MESH: Risk Factors; MESH: Treatment Outcome; MESH: Anticholesteremic Agents; MESH: Apolipoproteins B; MESH: Atherosclerosis; MESH: Cardiovascular Diseases; MESH: Cholesterol; MESH: Heart Disease Risk Factors; MESH: Humans; [SDV]Life Sciences [q-bio]
- 24
-
25
von Bittner, Vera A. ; Szarek, Michael ; Aylward, Philip E. ; et al.
0735-1097 ; Journal of the American College of Cardiology
Schlagworte: Human medicine
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag